PREVALIN V LEChENII SEZONNOGO ALLERGIChESKOGO RINITA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This study was aimed to the evaluation of the anti-inflammatory efficacy of combination of standard therapy of seasonal allergic rhinitis with the barrier preparation (Prevalin). The open perspective randomized comparative parallel-group study included 49 patients with moderate to severe seasonal allergic rhinitis caused by wormwood pollen sensitization. All patients were treated with intranasal glucocorticosteroids in combination with a non-sedating antihistamines, 30 patients additionally received Prevalin 4 times a day. The frequency and severity of symptoms during treatment, the need for drug therapy, standard laboratory parameters, the level of eosinophil cationic protein in serum and nasal contents were evaluated. The results showed that the use of Prevalin in addition to the standard pharmacotherapeutic complex promoted more rapid and effective suppression of disease symptoms, as well as support of pharmacological remission of the disease using a smaller volume of basic therapy. More rapid achievement of clinical effect was recorded against the background of a more effective suppression of allergic inflammation.

Full Text

Restricted Access

References

  1. Meitzer E.O. Evaluation of the optimal oral antihistamine for patient with allergic rhinitis. Mayo Clin. Proc. 2005; 80(9): 1170-76.
  2. Bousquet J., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 Update (in collaboration with World Health Organization, GA2LEN* and AllerGen). Allergy. 2008; 68(Suppl. 86): 8-160.
  3. Белан Э.Б., Садчикова Т.Л. Фенотипы формирования бронхиальной астмы у детей дошкольного возраста. Вестник ВолГМУ 2005; 2(16): 76-9. прил.
  4. Rondon C., еt al. Local allergic rhinitis: concept, pathophysiology and management. J Allergy Clin. Immunol. 2012; 129(6): 1460-67.
  5. Brozek J.L., Bousquet J., Baena-Cagnani C.E., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin. Immunology. 2010; 126: 466-76
  6. Протокол ведения больных «Аллергический ринит». Проблемы стандартизации в здравоохранении 2007; 3: 23-88.
  7. Чехонина И.В. Иммунологические особенности течения аллерген-специфической иммунотерапии у детей, страдающих сезонным аллергическим ринитом, в условиях персистирующей естественной пыльцевой нагрузки. Дисс. канд. мед. наук. Волгоград, 2009.
  8. Mattila, et al. Allergy as an epithelial barrier disease. Clinical Translational Allergy. 2011; 1: 5-12.
  9. Цывкина А.А., Лусс Л.В., Царев С.В. Современный подход к лечению круглогодичного аллергического ринита. Doctor.ru. 2012; 4(82): 7-10.
  10. Белан Э.Б., Рудобаба Е.Л., Панина А.А. и др. Эффективность барьерных методов в лечении сезонного аллергического ринита. Doctor.ru. 2012; 4(82): 11-6.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies